The 20-year-old Jackson Heart Study—the largest long-term study of cardiovascular health in a defined population of African-Americans—has received another six years of funding from the National Heart, Lung and Blood Institute.

Chronic kidney disease is a marker of adverse outcomes in patients with non-ST-elevation myocardial infarction (non-STEMI), according to a study published this month in the American Journal of Cardiology. And even though percutaneous coronary intervention (PCI) and coronary angiography (CAG) are linked to improved outcomes in those patients, they’re also drastically underutilized in clinical practice.

DUBLIN – September 10, 2018 – Medtronic plc (NYSE:MDT) today announced the start of the Onyx ONE Clear Study in the U.S. and Japan that will evaluate one-month dual antiplatelet therapy (DAPT) in high bleeding risk patients implanted with the Resolute Onyx™ Drug-Eluting Stent (DES) during percutaneous coronary intervention (PCI).

A new review published in JAMA Internal Medicine adds to the growing body of evidence that physician burnout negatively impacts clinical outcomes, as burned-out doctors were twice as likely to be involved in patient safety incidents, provide suboptimal care as a result of low professionalism and garner low patient satisfaction ratings.

Fewer Americans smoked or were physically inactive in 2015-16 than four years earlier, but there were also fewer on “appropriate” aspirin therapy to prevent cardiovascular events, according to a Vital Signs report released by the CDC.

Joseph D. Babb, MD—who performed the first coronary angioplasty in the state of Connecticut and was a past president of the Society for Cardiovascular Angiography and Interventions (SCAI)—has died, SCAI announced Sept. 6. He was 79.

Early discharge following TAVR is associated with fewer readmissions and similar mortality over the following 30 days compared with a standard discharge strategy, according to a meta-analysis published in JACC: Cardiovascular Interventions.

London—September 7, 2018—BTG plc (LSE: BTG), the global specialist healthcare company, today announces it has acquired Novate Medical Ltd. (“Novate”), a medical device company focused on the prevention of pulmonary embolism (PE) in patients at high risk of venous thromboembolic events.

A peer-reviewed study published in Clinical Toxicology this week warns competitive athletes—and cardiac patients—against consuming supplements that might contain higenamine, a stimulant that’s poorly regulated and could pose a considerable threat to heart health.

Internet searches for terms related to cardiovascular disease (CVD) spiked in winter months in Australia and the United States, according to a study published in Mayo Clinic Proceedings. The search results were consistent with previously reported seasonal variations in CVD, suggesting they could eventually be used to predict disease incidence at the population level.